Simple Plex Viral Titer Assays


Detecting AAV intact capsids

PROGEN and ProteinSimple have teamed up to bring you our reliable AAV particle antibodies together with ProteinSimple’s robust automated immunoassay systems. 

The new Simple Plex assays exclusively detect adeno-associated virus (AAV) intact capsids in bioprocess samples, combining PROGEN’s established AAV antibodies with the convenient Ella platform workflow. The microfluidic cartridge offers a broad dynamic range and hands-free automation to accelerate cell and gene therapy process development.


View All Simple Plex Assays        Download App Note

Rocky mountain ridge with snow-covered tops

Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay

Simple Plex AAV2 assay combines the scalability and automation of Ella with best-in-class AAV reagents from PROGEN

MINNEAPOLIS, July 28, 2021 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) and PROGEN today announced the launch of the Simple Plex™ Adeno-Associated Virus (AAV2) viral titer assay for AAV2 total capsid quantification. Bio-Techne, owner of the leading ProteinSimple branded protein analysis portfolio of products, and PROGEN will offer the Simple Plex AAV2 viral titer assay on Ella™ instruments, its multiplexing immunoassay system. Combining the efficiency and reproducibility of the established AAV2 ELISAs from
PROGEN with the convenient workflow and robustness of the Ella platform, the Simple Plex AAV2 viral titer assay offers a broad dynamic range and hands-free automation to accelerate cell and gene therapy process development. Featuring antibodies from PROGEN, the Simple Plex AAV2 viral titer assay detects assembled viral capsids as well as the comprehensively characterized AAV2 standard to deliver industry leading specificity.

 

Download Press Release        

 

Know what you need?

Login and order directly
from your account

Order Now

Need more information?

Visit our support hub for FAQs,
references and downloads.

Visit Support Hub